AxoGen Competitors and Similar CompaniesClear all

AxoGen's competitors and similar companies include BioPerfectus.
AxoGen
AxoGen
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
BioPerfectus
BioPerfectus
BioPerfectus (also known as Jiangsu Bioperfectus Technologies, 江苏硕世生物科技股份有限公司) is a company focused on nucleic acid extraction systems, PCR-based assays, and related consumables.
Founding Date
Founding Date
2002
Founding Date
2010
Type
Type
Public
Type
Public
Tags
Locations
Locations
Alachua, US HQ
Burleson, US
Locations
Taizhou, CN HQ
Shanghai, CN
Belfast, GB
Natick, US
Employees
Employees
37133% increase
Employees
592
Valuation ($)
Valuation ($)
611.9 m
Valuation ($)
616.7 m

Financial

Revenue (est.)
Revenue (est.)
$225.2m (FY, 2025)
Revenue (est.)
¥324.6m (FY, 2024)
Cost of goods
Cost of goods
$57.9m (FY, 2025)
Cost of goods
¥132m (FY, 2024)
Gross profit
Gross profit
$167.4m (FY, 2025)
Gross profit
¥210.9m (FY, 2024)
Net income
Net income
($15.7m) (FY, 2025)
Net income
(¥2m) (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

BioPerfectus
HQ
Taizhou, CN
Employees
592

BioPerfectus (also known as Jiangsu Bioperfectus Technologies, 江苏硕世生物科技股份有限公司) is a company focused on nucleic acid extraction systems, PCR-based assays, and related consumables.

View company